HWAM
MIRM icon

Hennion & Walsh Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Hennion & Walsh Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39M Sell
37,492
-56,100
-60% -$5.63M 0.13% 212
2026
Q1 		$8.65M Sell
93,592
-4,702
-5% -$442K 0.29% 67
2025
Q4 		$7.76M Sell
98,294
-17,560
-15% -$1.26M 0.27% 73
2025
Q3 		$8.49M Sell
115,854
-6,915
-6% -$440K 0.31% 57
2025
Q2 		$6.25M Sell
122,769
-24,424
-17% -$1.09M 0.25% 75
2025
Q1 		$6.63M Buy
147,193
+1,594
+1% +$75.1K 0.29% 63
2024
Q4 		$6.02M Buy
145,599
+29,545
+25% +$1.23M 0.27% 76
2024
Q3 		$4.53M Buy
116,054
+11,284
+11% +$450K 0.21% 110
2024
Q2 		$3.58M Buy
104,770
+41,236
+65% +$1.08M 0.18% 134
2024
Q1 		$1.6M Buy
63,534
+15,022
+31% +$413K 0.09% 306
2023
Q4 		$1.43M Buy
48,512
+22,019
+83% +$666K 0.08% 316
2023
Q3 		$837K Buy
26,493
+12,516
+90% +$343K 0.05% 399
2023
Q2 		$362K Buy
+13,977
New +$372K 0.02% 602

Other funds holding MIRM

NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Hennion & Walsh Asset Management's MIRM Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 60% in Q2 2026, selling an estimated $5.63M and leaving 37,492 shares worth $4.39M. The position accounts for 0.13% of the portfolio, ranked #212.

Hennion & Walsh Asset Management first reported a position in MIRM in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.65M in Q1 2026. 45 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Hennion & Walsh Asset Management held 37,492 shares of Mirum Pharmaceuticals worth $4.39M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 56,100 Mirum Pharmaceuticals shares in Q2 2026, an estimated $5.63M.
  • Mirum Pharmaceuticals made up 0.13% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #212 holding.
  • Hennion & Walsh Asset Management first reported a position in Mirum Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Hennion & Walsh Asset Management's Mirum Pharmaceuticals position peaked at $8.65M in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.